1. Home
  2. ACTU vs CBNA Comparison

ACTU vs CBNA Comparison

Compare ACTU & CBNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTU
  • CBNA
  • Stock Information
  • Founded
  • ACTU 2015
  • CBNA 2006
  • Country
  • ACTU United States
  • CBNA United States
  • Employees
  • ACTU N/A
  • CBNA N/A
  • Industry
  • ACTU
  • CBNA
  • Sector
  • ACTU
  • CBNA
  • Exchange
  • ACTU NYSE
  • CBNA NYSE
  • Market Cap
  • ACTU 135.0M
  • CBNA 159.8M
  • IPO Year
  • ACTU 2024
  • CBNA 2024
  • Fundamental
  • Price
  • ACTU $6.55
  • CBNA $26.60
  • Analyst Decision
  • ACTU Strong Buy
  • CBNA Buy
  • Analyst Count
  • ACTU 1
  • CBNA 3
  • Target Price
  • ACTU $20.00
  • CBNA $29.67
  • AVG Volume (30 Days)
  • ACTU 143.8K
  • CBNA 31.8K
  • Earning Date
  • ACTU 05-15-2025
  • CBNA 08-15-2025
  • Dividend Yield
  • ACTU N/A
  • CBNA N/A
  • EPS Growth
  • ACTU N/A
  • CBNA 60.12
  • EPS
  • ACTU N/A
  • CBNA 4.10
  • Revenue
  • ACTU N/A
  • CBNA $57,087,000.00
  • Revenue This Year
  • ACTU N/A
  • CBNA N/A
  • Revenue Next Year
  • ACTU N/A
  • CBNA $17.50
  • P/E Ratio
  • ACTU N/A
  • CBNA $6.46
  • Revenue Growth
  • ACTU N/A
  • CBNA 62.88
  • 52 Week Low
  • ACTU $5.50
  • CBNA $20.01
  • 52 Week High
  • ACTU $11.99
  • CBNA $27.97
  • Technical
  • Relative Strength Index (RSI)
  • ACTU N/A
  • CBNA N/A
  • Support Level
  • ACTU N/A
  • CBNA N/A
  • Resistance Level
  • ACTU N/A
  • CBNA N/A
  • Average True Range (ATR)
  • ACTU 0.00
  • CBNA 0.00
  • MACD
  • ACTU 0.00
  • CBNA 0.00
  • Stochastic Oscillator
  • ACTU 0.00
  • CBNA 0.00

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

About CBNA CHAIN BRIDGE BANCORP INC

Chain Bridge Bancorp Inc is engaged in banking industry. It offers commercial and personal banking services, including deposits, treasury management, payments, loans, commercial lending, residential mortgage financing, consumer loans, trusts and estate administration, wealth management, and asset custody.

Share on Social Networks: